868 results on '"Blandino, G"'
Search Results
2. Patient-derived organoids: 3D miniature models of bladder cancer
3. COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)
4. MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
5. Workload and stress evaluation in advanced manufacturing systems
6. Impact of gut microbiota on diabetes mellitus
7. Refinement of MRD Assessment in Hairy Cell Leukemia by Integrated Molecular and Flow Cytometry Analysis
8. 70MO Genomic profiling to expand precision cancer medicine in the real world: The ROME trial
9. P05 Study of viral Biomarkers and MicroRNAs in HPV-associated Oropharyngeal cancer and cancer of unknown primary
10. 1665P Genomic mutational landscape of solid tumors: Preliminary results from ROME trial
11. LBA7 The Rome trial from histology to target: The road to personalize targeted therapy and immunotherapy
12. PO-1416 Dual Energy Computed Tomography Applications for Prostate Radiotherapy: Advantages in Target and OAR Contouring
13. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome.
14. Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
15. Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells
16. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma
17. The Hippo Pathway
18. Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
19. Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’: [ESMO Open Volume 6, Issue 3, June 2021, 100165]
20. Additional file 14 of MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
21. METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors
22. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
23. Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation
24. 521P Deciphering a three-miRNA signature as a prognostic biomarker in glioma patients: Correlation with DFS and OS
25. A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes
26. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients
27. Mutant p53: an oncogenic transcription factor
28. S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation
29. DNp73α protects myogenic cells from apoptosis
30. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression
31. LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism
32. Surgical site infection in elderly patients
33. Analysis of p73 expression pattern in acute myeloid leukemias: lack of ΔN-p73 expression is a frequent feature of acute promyelocytic leukemia
34. OC-0611: APBI with 3D-CRT vs. WBI: cosmetic and toxicity results of the prospective randomised IRMA trial
35. Radiomics Analysis of Stereotactic Body Radiation Therapy Patients with Lung Cancer as a Toxicity Biomarker
36. Internalization-associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis
37. p53-paralog DNp73 oncogene is repressed by IFNa/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor
38. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging
39. Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut
40. Long non-coding RNAs contribution to cell migration and lipid metabolism in thymic epithelial tumor cells
41. Virulence factors and antibiotic resistance in uropathogenic Escherichia coli: P664
42. E6AP Promotes a Metastatic Phenotype in Prostate Cancer
43. Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells
44. Susceptibility of 461 Nosocomial Gram-Negative Pathogens to Enoxacin and Other Antibiotics
45. Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates
46. ANTIBACTERIAL ACTIVITY OF MOXIFLOXACIN AGAINST PERIODONTAL ANAEROBE PATHOGENS INVOLVED IN SYSTEMIC INFECTIONS
47. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia
48. Are intraoral customized stents still necessary in the era of Highly Conformal Radiotherapy for Head & Neck cancer? Case series and literature review
49. In Vitro Activity and Clinical Efficacy of Ciprofloxacin in Otorhinolaryngeal Infections
50. Activity of Ciprofloxacin against Respiratory Pathogens Capable of Producing β-Lactamase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.